A Study of LY2775240 in Healthy Participants

NCT02963779 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY2775240
DRUG: Placebo
DRUG: Apremilast

Sponsor

Eli Lilly and Company